BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer von Shahbandi, Ashkan, Rao, Sonia G., Anderson, Ashlyn Y., Frey, Wesley D., Olayiwola, Joy O., Ungerleider, Nathan A., Jackson, James G.

Volltext

Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment von Ungerleider, Nathan A, Rao, Sonia G, Shahbandi, Ashkan, Yee, Douglas, Niu, Tianhua, Frey, Wesley D, Jackson, James G

Volltext

Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity von Shahbandi, Ashkan, Jackson, James G.

Volltext

BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response inTP53wild-type breast cancer von Shahbandi, Ashkan, Rao, Sonia G., Anderson, Ashlyn Y., Frey, Wesley D., Olayiwola, Joy O., Ungerleider, Nathan A., Jackson, James G.

Volltext

Medical students’ ability to diagnose common dermatologic conditions in skin of color von Fenton, Anne, Elliott, Erika, Shahbandi, Ashkan, Ezenwa, Ekene, Morris, Chance, McLawhorn, Justin, Jackson, James G., Allen, Pamela, Murina, Andrea

Volltext

TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines von Shahbandi, Ashkan, Nguyen, Hoang D., Jackson, James G.

Volltext

Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival von Tonnessen-Murray, Crystal A, Frey, Wesley D, Rao, Sonia G, Shahbandi, Ashkan, Ungerleider, Nathan A, Olayiwola, Joy O, Murray, Lucas B, Vinson, Benjamin T, Chrisey, Douglas B, Lord, Christopher J, Jackson, James G

Volltext

Nation-wide trends in mortality of patients with ocular and orbit melanoma: 2000 to 2014 von Forehand, William, Gopishetty, Swathi, Shahbandi, Ashkan, Guddati, Achuta Kumar

Volltext

Analysis of race and gender disparities in incidence-based mortality in patients diagnosed with thyroid cancer from 2000 to 2014 von Cintron-Garcia, Juan, Pappoppula, Lakshmi Priyanka, Shahbandi, Ashkan, Komiya, Takefumi, Guddati, Achuta

Volltext

Could senescence phenotypes strike the balance to promote tumor dormancy? von Chiu, Fang-Yen, Kvadas, Raegan M., Mheidly, Zeinab, Shahbandi, Ashkan, Jackson, James G.

Volltext

cfDNA TP53 mutations with treatment history and disease progression in metastatic CRPC von Chapman, Lynne, Ledet, Elisa, Moses, Marcus Marie, Shahbandi, Ashkan, Steinwald, Peter, Christensen, Bryce Raymon, Cotogno, Patrick, Schiff, Joshua, Layton, Jodi Lyn, Lewis, Brian E., Sartor, A. Oliver

Volltext

cfDNA analysis of mCRPC patients expressing mutations in Wnt signaling von Shahbandi, Ashkan, Ledet, Elisa, Christensen, Bryce Raymon, Moses, Marcus Marie, Steinwald, Peter, Chapman, Lynne, Cotogno, Patrick, Layton, Jodi Lyn, Lewis, Brian E., Schiff, Joshua, Sartor, A. Oliver

Volltext

Cosegregation of cfDNA AR amplifications and mutations in relation to BRAF and MYC in CRPC von Christensen, Bryce Raymon, Ledet, Elisa, Moses, Marcus Marie, Chapman, Lynne, Steinwald, Peter, Shahbandi, Ashkan, Cotogno, Patrick, Schiff, Joshua, Layton, Jodi Lyn, Lewis, Brian E., Sartor, A. Oliver

Volltext

Cell-free DNA (cfDNA) analysis and evaluation of BRAF amplifications and mutations in metastatic castration-resistant prostate cancer von Steinwald, Peter, Ledet, Elisa, Christensen, Bryce Raymon, Moses, Marcus Marie, Chapman, Lynne, Shahbandi, Ashkan, Cotogno, Patrick, Schiff, Joshua, Layton, Jodi Lyn, Lewis, Brian E., Sartor, A. Oliver

Volltext

Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80 von Shahbandi, Ashkan, Chiu, Fang-Yen, Ungerleider, Nathan A, Kvadas, Raegan, Mheidly, Zeinab, Sun, Meijuan J S, Tian, Di, Waizman, Daniel A, Anderson, Ashlyn Y, Machado, Heather L, Pursell, Zachary F, Rao, Sonia G, Jackson, James G

Volltext

Connective Tissue Growth Factor Induces Anti-Apoptotic Factors in Chronic Myeloid Leukemia Stem Cells von Chang, Patrick C, Low-Marchelli, Janine M, Shahbandi, Ashkan, Goff, Daniel J, Jamieson, Catriona

Volltext

Abstract 1297: Chemotherapy-induced senescence activates robust, parallel programs of immune checkpoint expression that can be targeted with immunotherapy von Shahbandi, Ashkan, Chiu, Fang-Yen, Ungerleider, Nathan A., Anderson, Ashlyn Y., Machado, Heather L., Pursell, Zachary F., Kvadas, Raegan, Rao, Sonia G., Jackson, James G.

Volltext

Breast cancer cells survive chemotherapy by activating targetable immune modulatory programs characterized by either PD-L1 or CD80 von Shahbandi, Ashkan, Chiu, Fang-Yen, Ungerleider, Nathan A., Kvadas, Raegan, Mheidly, Zeinab, Sun, Meijuan J S, Tian, Di, Waizman, Daniel A., Anderson, Ashlyn Y., Machado, Heather L., Pursell, Zachary F., Rao, Sonia G., Jackson, James G.

Volltext

Abstract 3830: Novel small molecule translation inhibitors with safety and efficacy in triple negative breast cancer (TNBC) animal models von Fung, Leah, Chan, Kyle W. H., Ottilie, Sabine, Shahbandi, Ashkan, Grudzien-Nogalska, Ewa, Rhoads, Robert E., Swindlehurst, Cathy A.

Volltext

Two New Classes of Drugs to Target Chemotherapy Resistant and High Risk B-ALL von Swindlehurst, Cathy A., Fung, Leah, Chan, Kyle W.H., Ottilie, Sabine, Shahbandi, Ashkan, Morris, Christopher L., Francis, Oliva L, Bennet, Terrence, Martinez, Shannalee R, Payne, Kimberly J

Volltext